tiprankstipranks
Trending News
More News >
Alexandria Real Estate Equities (ARE)
NYSE:ARE
Advertisement

Alexandria Equities (ARE) AI Stock Analysis

Compare
1,083 Followers

Top Page

ARE

Alexandria Equities

(NYSE:ARE)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
$84.00
▲(13.64% Upside)
Alexandria Equities shows strong revenue growth and efficient cash flow management, which are positive indicators for future performance. The earnings call provided a balanced outlook with significant achievements and challenges. However, the negative P/E ratio and recent net loss are concerns that weigh on the overall score. The attractive dividend yield provides some support, but technical indicators suggest caution in the short term.
Positive Factors
Revenue Growth
The robust revenue growth rate of 22.6% TTM indicates strong demand for Alexandria's properties, supporting long-term business expansion and stability.
Largest Lease in Company History
Securing the largest lease in company history demonstrates Alexandria's strong market position and ability to attract high-credit tenants, ensuring stable future cash flows.
Strong Cash Flow Management
Efficient cash flow management, indicated by a high coverage ratio, supports Alexandria's ability to fund operations and growth initiatives, enhancing financial resilience.
Negative Factors
Net Loss and Negative ROE
The net loss and negative ROE highlight profitability challenges, potentially impacting shareholder value and limiting reinvestment capacity.
Occupancy Decline
Declining occupancy rates indicate challenges in maintaining leasing momentum, which could pressure revenue and profitability if not addressed.
Asset Impairments
Significant asset impairments reflect potential overvaluation of properties and could strain financial performance, affecting future earnings and balance sheet health.

Alexandria Equities (ARE) vs. SPDR S&P 500 ETF (SPY)

Alexandria Equities Business Overview & Revenue Model

Company DescriptionAlexandria Equities (ARE) is a leading real estate investment trust (REIT) specializing in the acquisition, development, and management of high-quality, innovative office and lab spaces primarily for the life sciences, technology, and agtech sectors. The company focuses on urban markets that foster innovation and collaboration, providing tenants with essential environments to thrive. Alexandria's portfolio includes properties designed to support cutting-edge research and development, catering to a diverse range of clients from biotech firms to academic institutions.
How the Company Makes MoneyAlexandria Equities generates revenue primarily through leasing its properties to tenants in the life sciences and technology sectors. The company's revenue model is based on long-term leases, which provide a stable income stream. Key revenue streams include rental income from both traditional office spaces and specialized lab facilities. Alexandria also engages in development projects, enhancing its portfolio's value and generating additional income through the eventual leasing of these newly developed spaces. Significant partnerships with universities and research institutions further contribute to its earnings by securing long-term tenants and fostering collaborative environments that attract additional clients.

Alexandria Equities Key Performance Indicators (KPIs)

Any
Any
Revenue By Segment
Revenue By Segment
Chart Insights
Data provided by:Main Street Data

Alexandria Equities Earnings Call Summary

Earnings Call Date:Jul 21, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 27, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant achievements such as the largest lease in company history and international recognition, indicating resilience and successful execution in key areas. However, challenges were evident in occupancy declines, public biotech market struggles, and asset impairments, creating a balanced outlook.
Q2-2025 Updates
Positive Updates
Largest Lease in Company History
Alexandria secured a 466,000 square foot lease, the largest in the company's history, demonstrating resilience and long-term commitment with a high credit tenant.
Significant Progress in Asset Sales
The company completed $1.1 billion in sales in the fourth quarter of 2024 and has about $1.1 billion more to add to their executable sales pipeline for the next two quarters.
International Building of the Year Award
Alexandria won its first international Building of the Year Award for 8 Davis Drive, a 150,000 square foot R&D building, showcasing operational excellence.
Strong Venture Funding in Life Sciences
Life Science venture funding remained steady with nearly $22 billion deployed in the first half of the year, highlighting resilience in the industry.
High Quality Tenant Base
75% of annual rental revenue comes from the highly distinguished Megacampus platform, with 53% of annual rental revenue from investment-grade or publicly traded large cap tenants.
Negative Updates
Occupancy Decline
Occupancy at the end of the quarter was 90.8%, down 90 basis points from the prior quarter, reflecting challenges in maintaining leasing momentum.
Challenges in Public Biotech Markets
The public biotech equity market remains tough with no biotech IPOs in the second quarter, and the risk-off environment is affecting leasing decisions.
Same Property NOI Decline
Same property NOI was down 5.4% for the quarter due to recent declines in occupancy and the burn-off of initial free rent from last year.
Increased Free Rent Concessions
Free rent was elevated during the quarter, which, though it helped secure long-term leases, indicates challenges in tenant acquisition.
Asset Impairments
Recognized impairments of real estate of $129.6 million during the quarter, impacting financial performance.
Company Guidance
During the second quarter of 2025, Alexandria Real Estate Equities reported solid performance amidst macroeconomic challenges, highlighting several key metrics and strategic initiatives. The company executed the largest lease in its history, a 466,000 square foot build-to-suit, which underscores the trust and value of Alexandria's brand. The quarter's occupancy stood at 90.8%, with a year-end target between 90.9% and 92.5%. Same-property NOI decreased by 5.4%, while cash-based NOI increased by 2%. The company completed approximately 770,000 square feet of leasing, with tenant improvements and leasing commissions on renewals down 40% from previous quarters. Alexandria plans to add $1.1 billion to its sales pipeline over the next two quarters, having already completed $1.1 billion in sales in Q4 2024. Additionally, Alexandria reported $60 million in gains from venture investments for the first half of 2025. The company maintains a robust balance sheet with corporate credit ratings in the top 10% of all publicly traded U.S. REITs and liquidity of $4.6 billion, aiming to achieve a year-end leverage target of 5.2x net debt to adjusted EBITDA.

Alexandria Equities Financial Statement Overview

Summary
Alexandria Equities shows strong revenue growth and efficient cash flow management. However, the recent net loss and negative return on equity are significant concerns impacting long-term profitability and shareholder value.
Income Statement
65
Positive
Alexandria Equities shows a strong revenue growth rate of 22.6% TTM, indicating robust top-line expansion. However, the net profit margin has turned negative TTM, primarily due to a net loss, which raises concerns about profitability. The gross profit margin remains healthy at approximately 69.6%, and the EBIT margin is stable at 17.3%, suggesting operational efficiency despite the net loss.
Balance Sheet
58
Neutral
The company's debt-to-equity ratio is relatively low at 0.71, indicating moderate leverage. However, the return on equity has turned negative TTM, reflecting the net loss and impacting shareholder returns. The equity ratio is stable, suggesting a solid capital structure, but the negative ROE is a concern.
Cash Flow
70
Positive
Operating cash flow remains strong with a high coverage ratio of 6.18 TTM, indicating good cash generation relative to net income. Free cash flow growth is positive at 3.53% TTM, showing improvement. The free cash flow to net income ratio is 1.0, highlighting efficient cash conversion despite the net loss.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.04B3.05B2.84B2.59B2.11B1.89B
Gross Profit2.12B2.14B1.98B1.81B1.49B1.36B
EBITDA1.84B1.90B1.45B1.63B1.35B1.23B
Net Income-12.85M322.95M103.64M521.66M416.83M591.20M
Balance Sheet
Total Assets37.62B37.53B36.77B35.52B30.22B22.83B
Cash, Cash Equivalents and Short-Term Investments520.54M552.15M618.19M825.19M361.35M568.53M
Total Debt13.66B12.75B11.70B10.57B9.23B7.91B
Total Liabilities15.88B15.13B14.15B12.84B11.19B9.38B
Stockholders Equity17.18B17.89B18.47B18.97B16.19B11.73B
Cash Flow
Free Cash Flow1.42B1.50B1.63B1.29B-6.32B-2.39B
Operating Cash Flow1.42B1.50B1.63B1.29B1.01B882.51M
Investing Cash Flow-1.03B-1.51B-2.50B-5.08B-7.11B-3.28B
Financing Cash Flow-425.32M-93.31M674.16M4.23B5.92B2.75B

Alexandria Equities Technical Analysis

Technical Analysis Sentiment
Negative
Last Price73.92
Price Trends
50DMA
79.64
Negative
100DMA
76.16
Negative
200DMA
81.47
Negative
Market Momentum
MACD
-1.34
Positive
RSI
26.73
Positive
STOCH
4.12
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARE, the sentiment is Negative. The current price of 73.92 is below the 20-day moving average (MA) of 82.13, below the 50-day MA of 79.64, and below the 200-day MA of 81.47, indicating a bearish trend. The MACD of -1.34 indicates Positive momentum. The RSI at 26.73 is Positive, neither overbought nor oversold. The STOCH value of 4.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARE.

Alexandria Equities Risk Analysis

Alexandria Equities disclosed 11 risk factors in its most recent earnings report. Alexandria Equities reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Alexandria Equities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$4.72B21.474.06%5.46%2.26%10.15%
68
Neutral
$6.24B21.789.67%4.37%2.95%
67
Neutral
$4.47B72.101.30%4.81%13.07%-4.94%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
61
Neutral
$7.93B9.4014.93%1.95%1.38%4370.96%
61
Neutral
$12.79B102.63-0.12%7.14%3.12%-116.29%
61
Neutral
$12.10B3,509.600.07%5.24%3.24%-97.73%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARE
Alexandria Equities
73.92
-38.93
-34.50%
BXP
BXP
69.49
-10.65
-13.29%
CUZ
Cousins Properties
26.62
-2.35
-8.11%
KRC
Kilroy Realty
39.55
2.27
6.09%
VNO
Vornado Realty
37.97
-1.42
-3.60%
CDP
COPT Defense Properties
27.66
-2.35
-7.83%

Alexandria Equities Corporate Events

Executive/Board ChangesShareholder Meetings
Alexandria Equities Approves Key Proposals at Annual Meeting
Neutral
May 15, 2025

On May 13, 2025, Alexandria Real Estate Equities, Inc. held its 2025 Annual Meeting of Stockholders, where several key proposals were approved, including the amendment and restatement of the Amended 1997 Incentive Plan. This amendment increases the number of shares available for grant, specifies the treatment of performance-based awards in the event of a change of control, and clarifies the prohibition of granting stock options and stock appreciation rights. Additionally, the meeting saw the election of eight directors, approval of executive compensation, ratification of Ernst & Young LLP as auditors, and the approval of a stockholder proposal titled ‘Simple Majority Vote’.

The most recent analyst rating on (ARE) stock is a Hold with a $117.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 07, 2025